Clinical Trial Update: Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis [Phase 2]

View source ↗

Summary

Phase II randomized open-label trial evaluating atovaquone with pyrimethamine or with sulfadiazine for acute toxoplasmic encephalitis in HIV patients; trial com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Toxoplasmosis Cerebral

Drugs mentioned

• Atovaquone (Atovaquone)
• Pyrimethamine (Pyrimethamine)
• Sulfadiazine (Sulfadiazine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Toxoplasmosis, Cerebral, HIV Infections | Phase 2 | Status: COMPLETED